Denavir

SmithKline Beecham launching a $10 mil. direct-to-consumer campaign for its Rx topical cold sore cream (penciclovir 1%). The campaign will include 45- and 60-second TV spots during early morning, daytime network and cable programming as well as print ads in late July and August issues of People, Health and Cosmopolitan. Print ads will carry the tagline, "No face should have to face another cold sore alone," while the TV spots feature people hiding their faces with playing cards, newspapers and turtlenecks due to cold sore "embarrassment." Grey Advertising (New York City) developed the DTC campaign. In December, FDA's NDAC and Antiviral Drugs Advisory Committees voted against the switch of Denavir due to viral resistance concerns (1"The Tan Sheet" Dec. 7, 1998, pp. 3-8). The company received a "not approvable" letter from FDA this year, but said at the time it was still pursuing the switch (2"The Tan Sheet" May 3, p. 6)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

Ocaliva: Still No Clarity On Why EU Court Opposed Revocation Of Approval

 

Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By 

This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By 

We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.

Brazil Pilots Digital Drug Pack Inserts

 

A new pilot aims to take Brazil closer to ‘digital transformation.’

More from Pink Sheet

EMA’s PRIME Scheme Explored: Growing Designations - But Are Accelerated Assessments Slipping?

 

While the first six months of the year saw eight new drugs targeting a range of diseases enter the European Medicines Agency’s priority medicines scheme, and three PRIME-designated treatments go on to win EU marketing approval, use of the accelerated assessment mechanism appears to be limited.

Global Pharma Guidance Tracker - June 2025

 

Stay up to date on regulatory guidelines from around the world with the Pink Sheet’s Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

US FDA’s CRL Release More Incremental Than ‘Radical’ Transparency

 

The transparency initiative collects CRLs already made public in approval packages on its drugs@fda site to post on the openFDA public portal.